Healthy, elderly research participants who report being more sleepy and less rested have higher levels of amyloid deposition in regions of the brain that are affected in Alzheimer's disease, according to a report presented ...
Dec 9, 2014
0
1
Researchers at the University of Adelaide are conducting world-first modelling of a range of naturally occurring molecules in the hopes of finding a perfect match that could one day be used in a new drug to help treat or ...
Dec 9, 2014
0
1
It is estimated that about 35 million people worldwide currently suffer from dementia and it is expected that the number will increase to 135 million by the year 2050. The disease is already one of the most common health ...
Dec 8, 2014
0
0
Blocking a key receptor in brain cells that is used by oxygen free radicals could play a major role in neutralizing the biological consequences of Alzheimer's disease, according to researchers at Temple University.
Nov 18, 2014
0
0
A multi-institutional study has defined and established criteria for a new neurological disease closely resembling Alzheimer's disease called primary age-related tauopathy (PART). Patients with PART develop cognitive impairment ...
Nov 13, 2014
0
0
(Medical Xpress)—A team of researches with the biotech firm Genentech Inc has found a way to carry an antibody across the blood-brain barrier using transferrin in a monkey. In their paper published in the journal Science ...
An innovative laboratory culture system has succeeded, for the first time, in reproducing the full course of events underlying the development of Alzheimer's disease. Using the system they developed, investigators from the ...
Oct 12, 2014
1
0
Alzheimer's disease experts at NYU Langone Medical Center and elsewhere are reporting success in specifically harnessing a mouse's immune system to attack and remove the buildup of toxic proteins in the brain that are markers ...
Sep 8, 2014
0
0
Swinburne researchers have developed a technique to create a highly sensitive surface for measuring the concentration of a peptide that is a biomarker for early stage Alzheimer's disease.
Sep 1, 2014
0
0
Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer's disease, a recent study from neuroscientists at the University of South Florida ...
Aug 27, 2014
1
1
